These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 29047108)

  • 1. Clinicopathologic characteristics and outcomes of transformed diffuse large B-cell lymphoma in hepatitis C virus-infected patients.
    Hosry J; Miranda RN; Samaniego F; Economides MP; Torres HA
    Int J Cancer; 2018 Mar; 142(5):940-948. PubMed ID: 29047108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiviral therapy improves overall survival in hepatitis C virus-infected patients who develop diffuse large B-cell lymphoma.
    Hosry J; Mahale P; Turturro F; Miranda RN; Economides MP; Granwehr BP; Torres HA
    Int J Cancer; 2016 Dec; 139(11):2519-28. PubMed ID: 27501007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C virus and diffuse large B-cell lymphoma: Pathogenesis, behavior and treatment.
    Visco C; Finotto S
    World J Gastroenterol; 2014 Aug; 20(32):11054-61. PubMed ID: 25170194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathologic characteristics of follicular lymphoma in hepatitis C virus-infected patients.
    Hosry J; Miranda RN; Samaniego F; Angelidakis G; Torres HA
    Hematol Oncol; 2020 Aug; 38(3):301-308. PubMed ID: 32196714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C Virus Infection and Treatment as Independent Prognostic Factors in Diffuse Large B-Cell Lymphoma Egyptian Patients.
    Elbedewy TA; Elashtokhy HEA; Abd-Elsalam S; Suliman MA
    Curr Cancer Drug Targets; 2020; 20(8):638-645. PubMed ID: 32392114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral therapy is associated with a better survival in patients with hepatitis C virus and B-cell non-Hodgkin lymphomas, ANRS HC-13 lympho-C study.
    Michot JM; Canioni D; Driss H; Alric L; Cacoub P; Suarez F; Sibon D; Thieblemont C; Dupuis J; Terrier B; Feray C; Tilly H; Pol S; Leblond V; Settegrana C; Rabiega P; Barthe Y; Hendel-Chavez H; Nguyen-Khac F; Merle-Béral H; Berger F; Molina T; Charlotte F; Carrat F; Davi F; Hermine O; Besson C;
    Am J Hematol; 2015 Mar; 90(3):197-203. PubMed ID: 25417909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The NOTCH pathway is recurrently mutated in diffuse large B-cell lymphoma associated with hepatitis C virus infection.
    Arcaini L; Rossi D; Lucioni M; Nicola M; Bruscaggin A; Fiaccadori V; Riboni R; Ramponi A; Ferretti VV; Cresta S; Casaluci GM; Bonfichi M; Gotti M; Merli M; Maffi A; Arra M; Varettoni M; Rattotti S; Morello L; Guerrera ML; Sciarra R; Gaidano G; Cazzola M; Paulli M
    Haematologica; 2015 Feb; 100(2):246-52. PubMed ID: 25381127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinico-biological characteristics and outcome of hepatitis C virus-positive patients with diffuse large B-cell lymphoma treated with immunochemotherapy.
    Dlouhy I; Torrente MÁ; Lens S; Rovira J; Magnano L; Giné E; Delgado J; Balagué O; Martínez A; Campo E; Forns X; Sánchez-Tapias JM; López-Guillermo A
    Ann Hematol; 2017 Mar; 96(3):405-410. PubMed ID: 28035434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Splenic large B-cell lymphoma in patients with hepatitis C virus infection.
    Takeshita M; Sakai H; Okamura S; Oshiro Y; Higaki K; Nakashima O; Uike N; Yamamoto I; Kinjo M; Matsubara F
    Hum Pathol; 2005 Aug; 36(8):878-85. PubMed ID: 16112004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of treatment-related toxicity on outcome of HCV-positive diffuse large B-cell lymphoma in rituximab era.
    Zaky AH; Bakry R; El-sayed MI; Elwanis MA; Nabih O
    Hematology; 2014 Oct; 19(7):412-6. PubMed ID: 24620947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic impact of hepatitis C virus infection in patients with diffuse large B-cell lymphoma treated with immunochemotherapy in the context of a novel prognostic index.
    Chen YY; Huang CE; Liang FW; Lu CH; Chen PT; Lee KD; Chen CC
    Cancer Epidemiol; 2015 Jun; 39(3):382-7. PubMed ID: 25899771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinctive natural history in hepatitis C virus positive diffuse large B-cell lymphoma: analysis of 156 patients from northern Italy.
    Visco C; Arcaini L; Brusamolino E; Burcheri S; Ambrosetti A; Merli M; Bonoldi E; Chilosi M; Viglio A; Lazzarino M; Pizzolo G; Rodeghiero F
    Ann Oncol; 2006 Sep; 17(9):1434-40. PubMed ID: 16766591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early-stage splenic diffuse large B-cell lymphoma is highly associated with hepatitis C virus infection.
    Yu SC; Lin CW
    Kaohsiung J Med Sci; 2013 Mar; 29(3):150-6. PubMed ID: 23465418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C infection is associated with hepatic toxicity but does not compromise the survival of patients with diffuse large B cell lymphoma treated with rituximab-based chemotherapy.
    Chen TT; Chiu CF; Yang TY; Lin CC; Sargeant AM; Yeh SP; Liao YM; Bai LY
    Leuk Res; 2015 Feb; 39(2):151-6. PubMed ID: 25524176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of new direct antiviral agents in hepatitis C virus-infected patients with diffuse large B-cell non-Hodgkin's lymphoma.
    Persico M; Aglitti A; Caruso R; De Renzo A; Selleri C; Califano C; Abenavoli L; Federico A; Masarone M
    Hepatology; 2018 Jan; 67(1):48-55. PubMed ID: 28714143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B virus-associated diffuse large B-cell lymphoma: unique clinical features, poor outcome, and hepatitis B surface antigen-driven origin.
    Deng L; Song Y; Young KH; Hu S; Ding N; Song W; Li X; Shi Y; Huang H; Liu W; Zheng W; Wang X; Xie Y; Lin N; Tu M; Ping L; Ying Z; Zhang C; Sun Y; Zhu J
    Oncotarget; 2015 Sep; 6(28):25061-73. PubMed ID: 26314957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological features and outcome of diffuse large B-cell lymphoma associated with hepatitis C virus in elderly patients: Results of the prospective 'Elderly Project' by the Fondazione Italiana Linfomi.
    Arcari A; Tabanelli V; Merli F; Marcheselli L; Merli M; Balzarotti M; Zilioli VR; Fabbri A; Cavallo F; Casaluci GM; Tucci A; Puccini B; Pennese E; Di Rocco A; Zanni M; Flenghi L; Gini G; Sartori R; Chiappella A; Usai SV; Tani M; Marino D; Arcaini L; Vallisa D; Spina M
    Br J Haematol; 2023 May; 201(4):653-662. PubMed ID: 36733229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics and outcome of diffuse large B-cell lymphoma in hepatitis C virus-positive patients in LNH 93 and LNH 98 Groupe d'Etude des Lymphomes de l'Adulte programs.
    Besson C; Canioni D; Lepage E; Pol S; Morel P; Lederlin P; Van Hoof A; Tilly H; Gaulard P; Coiffier B; Gisselbrecht C; Brousse N; Reyes F; Hermine O;
    J Clin Oncol; 2006 Feb; 24(6):953-60. PubMed ID: 16418500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does the presence of hepatitis virus B and C influence the evolution of diffuse large B-cell lymphoma?
    Rubio J; Franco F; Sánchez A; Cantos B; Méndez M; Calvo V; Maximiano C; Perez D; Millán I; Sánchez-Beato M; Provencio M
    Leuk Lymphoma; 2015 Jun; 56(6):1686-90. PubMed ID: 25219591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological features of HCV-positive splenic diffuse large B cell lymphoma.
    Shimono J; Miyoshi H; Arakawa F; Yamada K; Sugio T; Miyawaki K; Eto T; Miyagishima T; Kato K; Nagafuji K; Akashi K; Teshima T; Ohshima K
    Ann Hematol; 2019 May; 98(5):1197-1207. PubMed ID: 30729289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.